Detailed Narrative
Robust Q2 and H1 FY26 Performance
Stallion India Fluorochemicals Ltd. delivered strong financial results for Q2 FY26, with total revenues reaching INR 105.75 crores, marking a 55.6% YoY growth. EBITDA surged nearly seven-fold to INR 15.77 crores, and PAT increased to INR 11.42 crores, with margins expanding to 14.9%. For the first half of FY26, total revenue was INR 216.3 crores (52.8% YoY growth), and PAT increased by 135% to INR 21.78 crores. The company has already achieved over 50% of its full-year revenue guidance of INR 430 crores.
Strategic Capacity Expansion and Backward Integration
The company is aggressively pursuing backward integration and capacity expansion. The 10,000 metric ton R32 manufacturing facility in Bhilwara, Rajasthan, is under development with a minimum CapEx of INR 200 crores, aiming for operationalization within 9 months (by July 2026). The Mambattu facility in Andhra Pradesh, initially planned with INR 20 crores CapEx, has been enhanced 2.5 times to increase blending and debulking capacity for HFO refrigerants and specialty gases, targeting operationalization by January end. The Khalapur facility, with an IPO-outlined CapEx of INR 30 crores, is expected to be operational by December end or January max.
Entry into High-Purity Semiconductor Gases
Stallion is expanding its Khalapur facility to strengthen its footprint in liquid helium and high-purity semiconductor gases, targeting India's emerging electronic, solar, and fiber optic industries. The company aims for 6N purity (99.999999%) helium, requiring specialized handling, testing capabilities, and cylinder conditioning. The approval process for semiconductor gases is rigorous, taking 2-3 years, but creates a significant competitive moat and pricing power once qualified. This move aligns with the Prime Minister's push for semiconductor self-reliance.
Refrigerant Quota System and Market Dynamics
The upcoming refrigeration quota system (Kigali Accord) for 2028 will be based on baseline years (2024-2026) and will feature tradable quotas, guiding the industry towards lower Global Warming Potential (GWP) products like HFOs. While India's R32 manufacturing capacity currently exceeds domestic demand (16,000-18,000 metric tonnes demand vs. 30,000-40,000 tonnes capacity), the profitable segment is exports. Demand is expected to grow with the AC/refrigeration industry (15-20% YoY) and increasing use of R32 in HFO blends, with China's capacity reductions happening earlier than India's.
Margin Outlook and Cyclicality Management
The company expects significant margin expansion with backward integration. The Bhilwara R32 plant is projected to achieve a PAT margin of 24%, and the helium business 16-18%. While current business margins are optimal, the new manufacturing activities are expected to drive overall profitability. Management acknowledges the cyclical nature of products like helium but aims to balance this through a diversified product portfolio across the fluorochemical range, ensuring steady growth and mitigating demand cyclicality in end-user industries.
Funding Strategy and Internal Accruals
Stallion is funding its current expansion projects, including the Bhilwara R32 plant and the enhanced Mambattu and Khalapur facilities, primarily through internal accruals. Management emphasized that the company has sufficient funds from its current profitability (INR 40 crore PAT, INR 20 crore PAT) for these smaller requirements. They stated that they would approach the market for funding only when larger capital requirements, such as future AHF/MDC (INR 450-500 crores) or HFO (INR 500-700 crores) backward integration, arise.